Browsing Tag
Taiwan
70 posts
Why Taiwan’s anti-Indian worker billboard row has become a test for India Taiwan ties
Taiwan needs foreign workers, but anti-Indian campaign messaging is testing whether labour policy can survive local election politics.
Insider trades at Microsoft, Taiwan Semiconductor and Snap highlight different investor signals
Insider trades at Microsoft, Taiwan Semiconductor and Snap are drawing attention. Find out what these moves really signal for investors.
Trump leaves Taiwan arms sale undecided after Xi warning in Beijing talks
Taiwan needs deterrence. China wants restraint. Donald Trump’s arms sale pause turns one weapons package into an Indo Pacific credibility test.
Xi warns Trump on Taiwan as US and China push trade deals in Beijing
Trump and Xi are chasing trade stability. Taiwan remains the fault line that could still pull United States China ties into crisis.
Why Taiwan just locked in its largest ever defence budget and what it does not buy
Taiwan committed to NATO-style 5% defence spending by 2030. The NT$780 billion vote shows lawmakers want deterrence, but on the opposition's terms.
Foxconn wants more than factories. Its new LEO satellites show where it may be heading
Foxconn is testing space ambitions beyond electronics. PEARL satellites may reveal whether 2317.TW can scale LEO manufacturing.
Japan snap election delivers historic supermajority for Sanae Takaichi and ruling coalition
Japan’s snap election gives Prime Minister Sanae Takaichi a historic supermajority. Read how the result reshapes Japan’s economy, security policy, and diplomacy.
With Zhang Youxia gone, Taiwan fears fewer voices for caution in China’s military
China’s removal of General Zhang Youxia signals deeper shifts in PLA leadership and raises concerns over Taiwan risk. Read what NBC News reporting reveals.
Greater Changhua wind farms complete turbine phase, Ørsted eyes Q3 2026 commercial operation
Ørsted just completed wind turbine installation at Taiwan’s 920 MW Greater Changhua project. Find out why this matters for Asia’s offshore wind future.
Foresee Pharmaceuticals licenses MMP-12 pipeline to Primevera in $594m reset to double down on CAMCEVI and injectables
Foresee signs $594 million licensing deal with Primevera Therapeutics to exit MMP-12 R&D and focus on CAMCEVI injectables. Read what this signals for biotech strategy.